Recent studies have shown that tumor cells can use the Purinergic pathway to promote their proliferation, invasion, angiogenesis, and immune escape by increasing the production and release of purine nucleotide derivatives and altering the expression and sensitivity of Purinergic receptors [10]. This evidence concerns the gene P2RX4 and neoplasm.